Article

Hemofarm has commissioned a 4 MW rooftop solar power plant at its facility in Vršac, Serbia, as part of its decarbonization strategy. The EUR 3 million investment aims to cover approximately 12% of the site's electricity consumption and is expected to reduce annual CO2 emissions by 3,000-3,500 tons.

The solar installation spans 21,000 square meters and consists of about 8,000 solar panels, projected to generate around 5 million kWh annually. In peak summer months, it is anticipated to supply up to 50% of the electricity needed, aiding in stabilizing energy costs. The project included roof reinforcements and an advanced monitoring system.